Strategy Asset Managers LLC Abbott Laboratories Transaction History

Strategy Asset Managers LLC

$506 Million
Q2 2024

A detailed history of Strategy Asset Managers LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Strategy Asset Managers LLC holds 6,219 shares of ABT stock, worth $737,573. This represents 0.13% of its overall portfolio holdings.

Number of Shares

6,219

Previous 8,463 26.52%

Holding current value

$737,573

Previous $961,000 32.78%

% of portfolio

0.13%

Previous 0.21%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$100.73 - $112.44 $226,038 - $252,315	-2,244 Reduced 26.52%	6,219 $646,000
Q1 2024 Apr 25, 2024	BUY	$109.52 - $120.96 $203,159 - $224,380	1,855 Added 28.07%	8,463 $961,000
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $16,594 - $20,313	-184 Reduced 2.71%	6,608 $727,000
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $54,738 - $65,677	573 Added 9.21%	6,792 $657,000
Q2 2023 Aug 24, 2023	BUY	$100.78 - $112.29 $38,497 - $42,894	382 Added 6.54%	6,219 $677,000
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $65,767 - $77,412	-679 Reduced 10.42%	5,837 $591,000
Q4 2022 Jan 13, 2023	BUY	$95.06 - $111.52 $4,277 - $5,018	45 Added 0.7%	6,516 $715,000
Q3 2022 Oct 11, 2022	BUY	$96.76 - $112.03 $329,564 - $381,574	3,406 Added 111.13%	6,471 $626,000
Q2 2022 Jul 13, 2022	SELL	$102.07 - $123.37 $170,865 - $206,521	-1,674 Reduced 35.32%	3,065 $333,000
Q1 2022 Apr 11, 2022	BUY	$114.02 - $139.04 $35,232 - $42,963	309 Added 6.98%	4,739 $561,000
Q4 2021 Jan 14, 2022	SELL	$115.53 - $141.46 $78,098 - $95,626	-676 Reduced 13.24%	4,430 $623,000
Q3 2021 Dec 14, 2021	SELL	$116.66 - $129.06 $658,079 - $728,027	-5,641 Reduced 52.49%	5,106 $603,000
Q2 2021 Aug 04, 2021	BUY	$105.79 - $124.53 $18,619 - $21,917	176 Added 1.66%	10,747 $1.25 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $669,148 - $788,358	6,148 Added 139.0%	10,571 $1.27 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $24,885 - $27,117	-237 Reduced 5.09%	4,423 $485,000
Q3 2020 Nov 03, 2020	BUY	$91.64 - $111.29 $21,718 - $26,375	237 Added 5.36%	4,660 $508,000
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $53,981 - $69,090	705 Added 18.96%	4,423 $404,000
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $68,913 - $100,770	-1,097 Reduced 22.78%	3,718 $293,000
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $378,025 - $420,831	4,815 New	4,815 $418,000
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $53,931 - $62,900	-740 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $2.82 Million - $3.41 Million	-42,597 Reduced 98.29%	740 $59,000
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $51,923 - $58,821	-792 Reduced 1.79%	43,337 $3.14 Million
Q3 2018 Nov 01, 2018	BUY	$60.81 - $73.36 $2.68 Million - $3.24 Million	44,129 New	44,129 $0

Others Institutions Holding ABT

# of Institutions

3,167

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategy Asset Managers LLC with notifications on news.

Account

Strategy Asset Managers LLC Abbott Laboratories Transaction History